Leader in Specialized ED, OR and ICU Solutions Confirms Compliance of Picis ED PulseCheck Version 5.0 EDIS
WAKEFIELD, Mass.--(BUSINESS WIRE)-- Picis executives today weighed in on the final rules for the ARRA HITECH meaningful use criteria issued this week. The company commends policy makers for their comprehensive and diligent work to create a flexible, workable solution that lays the foundation for a strong electronic health record (EHR) plan for the future of U.S. health care. Serving the high-acuity areas of the hospital for more than 15 years, with an installed base of 1,800 facilities worldwide, Picis applauded the rules’ emphasis on the high-acuity areas – and specifically, the inclusion of the emergency department (ED) as an eligible place of service. This allows medication orders written electronically in the ED to qualify toward the requirements for Computerized Physician Order Entry (CPOE).
“Several of our executives worked directly with legislators, regulators and industry leaders to encourage the inclusion of the ED in the meaningful use final rule,” said Todd Cozzens, Picis CEO and Vice Chairman. “This final rule fully supports our ongoing commitment to helping to improve the delivery of care in the most cost- and care-intensive areas of the hospital. The new criteria will compel hospitals to implement robust solutions that will comply with all three stages of meaningful use. For example, a hospital that installs the Picis ED PulseCheck system today will be able to meet its entire hospital CPOE threshold in as little as nine months, thereby greatly accelerating our clients’ ability to capitalize on ARRA HITECH funding.”
Because many of the most important quality measures in the final rule apply directly to the high-acuity areas of the hospital – the ED, OR and ICU – Picis specialty solutions put hospitals in a better position to meet the quality and core measures in a timely manner. In the ED, Picis ED PulseCheck Version 5.0 already currently offers:
“Both existing Picis ED PulseCheck 5.0 customers and prospective customers can feel confident and secure that our specialty EDIS can help them overcome one of the biggest hurdles required in meaningful use – attaining the 30 percent compliance with CPOE for medication orders,” said Dr. Mark Crockett, M.D., F.A.C.E.P., President, Picis Emergency Care Division. “Our foresight with PulseCheck 5.0 puts us in position to move to next step – certification – as soon as Authorized Testing and Certifying Bodies (ATCBs) are identified.”
In the perioperative and critical care environments, Picis products are currently nearly 90 percent compliant with ARRA final rule requirements. The next release planned for Q1 2011 will be fully ARRA compliant, with application for certification from an ATCB to follow.
Picis is a global provider of innovative information solutions that enable rapid and sustained delivery of clinical, financial and operational results in the high-acuity care areas of the hospital. These high-acuity areas include the emergency department, operating and recovery rooms, and intensive care units. Picis offers the most advanced suite of integrated products focused on these life-critical areas of the hospital where the patients are the most vulnerable, the care process is the most complex and an increasing majority of hospital costs and potential revenue are concentrated. Headquartered in Wakefield, Massachusetts, Picis has licensed systems for use in more than 1,800 hospitals in 19 countries. For more information on Picis, please visit www.picis.com/solutions or to join a discussion on how cost containment and RAC impact emergency physicians or other issues, visit healthcare-exchange.com, Picis’ new blog. Follow Picis on Twitter at http://twitter.com/PicisInc.
© 2010 Picis, Inc. All rights reserved. Picis, CareSuite, ED PulseCheck, E/Point, may be trademarks or registered trademarks of Picis, Inc. in the United States and/or other countries. All other trademarks mentioned herein are the properties of their respective owners. This press release contains express or implied forward-looking statements relating to, among other things, Picis’ expectations concerning the functionality and market acceptance of its products, and management’s plans, objectives and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond Picis’ control, which could cause actual results to differ materially from those contemplated in these forward-looking statements.
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Technology Data Management Software Health Biotechnology Hospitals Medical Devices Pharmaceutical Other Health Nursing General Health